Transcriptomics

Dataset Information

0

The STEMRI trial: magnetic resonance spectroscopy imaging can define tumor areas enriched in glioblastoma-stem-like cells


ABSTRACT: Despite maximally-safe resection of the MRI-defined contrast-enhanced (CE) central tumor area and chemo-radiotherapy, most glioblastoma patients relapse within one year in peritumor FLAIR regions. Spectroscopic MRI (MRSI) can discriminate metabolic tumor areas with higher recurrence potential as CNI+ regions (Choline/N-acetyl-aspartate Index>2) can predict relapse sites. As relapses are mainly imputed to glioblastoma stem-like cells (GSC), CNI+ areas might be GSC-enriched. We conducted a prospective trial in 16 GBM patients subjected to preoperative MRSI/MRI and surgery/chemo-radiotherapy to investigate GSC content in CNI+ versus CNI- biopsies from CE/FLAIR. Biopsy characterization by RNAseq revealed that FLAIR/CNI+ areas were enriched in stem-related gene signature, but also in pathways related to DNA repair, adhesion/migration and mitochondrial bioenergetics.

ORGANISM(S): Homo sapiens

PROVIDER: GSE239379 | GEO | 2023/11/03

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2018-06-29 | GSE116414 | GEO
2017-03-08 | E-MTAB-3239 | biostudies-arrayexpress
2022-05-18 | GSE196141 | GEO
2015-01-06 | GSE60507 | GEO
2022-02-22 | PXD023118 | Pride
2015-01-06 | E-GEOD-60274 | biostudies-arrayexpress
2015-01-06 | E-GEOD-60507 | biostudies-arrayexpress
| PRJNA1018732 | ENA
2015-01-06 | GSE60274 | GEO
2024-02-13 | GSE255581 | GEO